Central serous chorioretinopathy in pregnancy.

Radu Ochinciuc, Mihnea Munteanu, George Baltă, Florian Baltă
{"title":"Central serous chorioretinopathy in pregnancy.","authors":"Radu Ochinciuc,&nbsp;Mihnea Munteanu,&nbsp;George Baltă,&nbsp;Florian Baltă","doi":"10.22336/rjo.2022.68","DOIUrl":null,"url":null,"abstract":"<p><p><b>Objective:</b> The objective of this work was to present two unusual cases of central serous chorioretinopathy (CSC) and the chosen therapeutic method. <b>Materials and methods:</b> In this article, two cases of CSC in pregnant patients were described. <b>Results:</b> The first case was a 35-year-old patient in the 16th week of pregnancy and the second one was a 26-year-old patient in the 20th week of pregnancy. Due to the contraindications associated to pregnancy, the therapeutic method chosen was subthreshold micropulse laser photocoagulation. The functional and anatomical evolution was very good in both patients. <b>Discussion:</b> In both cases, treatment of the disease was preferred to prevent important photoreceptor losses. After the treatment, very good anatomical and functional results were obtained. <b>Conclusions:</b> The micropulse laser is an effective solution for treating CSC. It is the only safe therapeutic solution during pregnancy. CSC can be associated with pregnancy, without necessarily suggesting pre-eclampsia. <b>Abbreviations:</b> CSC = central serous chorioretinopathy, SRF = subretinal fluid.</p>","PeriodicalId":21385,"journal":{"name":"Romanian journal of ophthalmology","volume":"66 4","pages":"382-385"},"PeriodicalIF":0.0000,"publicationDate":"2022-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9773112/pdf/","citationCount":"7","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Romanian journal of ophthalmology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.22336/rjo.2022.68","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 7

Abstract

Objective: The objective of this work was to present two unusual cases of central serous chorioretinopathy (CSC) and the chosen therapeutic method. Materials and methods: In this article, two cases of CSC in pregnant patients were described. Results: The first case was a 35-year-old patient in the 16th week of pregnancy and the second one was a 26-year-old patient in the 20th week of pregnancy. Due to the contraindications associated to pregnancy, the therapeutic method chosen was subthreshold micropulse laser photocoagulation. The functional and anatomical evolution was very good in both patients. Discussion: In both cases, treatment of the disease was preferred to prevent important photoreceptor losses. After the treatment, very good anatomical and functional results were obtained. Conclusions: The micropulse laser is an effective solution for treating CSC. It is the only safe therapeutic solution during pregnancy. CSC can be associated with pregnancy, without necessarily suggesting pre-eclampsia. Abbreviations: CSC = central serous chorioretinopathy, SRF = subretinal fluid.

Abstract Image

Abstract Image

Abstract Image

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
妊娠期中枢性浆液性脉络膜视网膜病变。
目的:本工作的目的是提出两个不寻常的中央浆液性脉络膜视网膜病变(CSC)和选择的治疗方法。材料与方法:本文报道2例妊娠期CSC患者。结果:1例患者35岁,孕16周;2例患者26岁,孕20周。由于与妊娠相关的禁忌症,治疗方法选择阈下微脉冲激光光凝。两例患者的功能和解剖进化都很好。讨论:在这两种情况下,首选的治疗方法是防止重要的光感受器丧失。治疗后,获得了很好的解剖和功能效果。结论:微脉冲激光是治疗CSC的有效方法。这是怀孕期间唯一安全的治疗方法。CSC可能与妊娠有关,但不一定意味着先兆子痫。缩写:CSC =中央浆液性脉络膜视网膜病变,SRF =视网膜下积液。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Rare case report: a 26-year-old man with Eales' disease. Apert Syndrome - caveats of squint management. Assessment of the efficacy of 0.1% cyclosporine A cationic emulsion in the treatment of dry eye disease during COVID-19 pandemic. Dynamics of the association between visual and auditory functional changes in glaucoma. Preliminary results. Decreased perifoveal ganglion cell complex thickness - a first sign for macular damage in patients using hydroxychloroquine.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1